Delta opioid receptors and low temperature myocardial protection.
BACKGROUND
Cardiac surgery continues to be limited by an inability to achieve complete myocardial protection. This may result from the use of hypothermic cardioplegia. Interestingly, the subcellular changes of animal hibernation parallel the altered biology of induced hypothermic myocardial ischemia, but are well tolerated by hibernated mammalian myocardium. Evidence indicates this protection is mediated by activation of the delta opioid receptor, which elicits profound metabolic effects at the whole animal, organ, and cell level. In this study, we sought to determine if pentazocine, with agonist activity at the delta opioid receptor, could improve myocardial recovery following global ischemia over a wide range of temperatures.


METHODS
Isolated rabbit hearts received either standard cardioplegia or were pretreated with racemic, d or 1 isomer pentazocine. Hearts were then subjected to 2 hours at 34 degrees C, or 3.5 hours at 20 degrees C, or 4 hours at 10 degrees C of cardioplegic ischemia and reperfused. Functional recovery was compared to controls.


RESULTS
Isovolumic developed pressure, coronary flow, oxygen consumption, and ultrastructural preservation were enhanced with pentazocine delta opioid mediated protection, which appears to be additive to standard cardioplegia, even at low temperatures.


CONCLUSIONS
Teleologically, delta opioid protection parallels animal hibernation, which occurs from 34 degrees down to 0 degrees C. The use of delta opioid receptor agonists may have important clinical implications for cardiac surgery and deserves further study.
Schwartz
C F
CF
Section of Cardiac Surgery, University of Michigan Hospitals, Ann Arbor 48109-0344, USA.
Georges
A J
AJ
Gallagher
M A
MA
Yu
L
L
Kilgore
K S
KS
Bolling
S F
SF
D000818:Animals; D003326:Coronary Circulation; D005260:Female; D006324:Heart Arrest, Induced; D007036:Hypothermia, Induced; D066298:In Vitro Techniques; D008297:Male; D015428:Myocardial Reperfusion Injury / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D009206:Myocardium / Q000378:metabolism / Q000648:ultrastructure; D010101:Oxygen Consumption; D010423:Pentazocine / Q000494:pharmacology*; D020011:Protective Agents / Q000494:pharmacology; D011817:Rabbits; D017465:Receptors, Opioid, delta / Q000819:agonists / Q000502:physiology*; D016277:Ventricular Function, Left
D020011:Protective Agents; D017465:Receptors, Opioid, delta; D010423:Pentazocine